α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Ashley R. Winslow(Pfizer (United States)), David C. Rubinsztein(UK Dementia Research Institute)
Cited by 819
Related Papers
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
|Nature Genetics|2004|2.3k
Molecular definitions of autophagy and related processes
|The EMBO Journal|2017|1.6k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Autophagy modulation as a potential therapeutic target for diverse diseases
|Nature Reviews Drug Discovery|2012|1.4k
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein
|Journal of Biological Chemistry|2006|1.1k